MY142579A - Aerosol formulation for inhalation comprising an anticholinergic - Google Patents

Aerosol formulation for inhalation comprising an anticholinergic

Info

Publication number
MY142579A
MY142579A MYPI20033067A MYPI20033067A MY142579A MY 142579 A MY142579 A MY 142579A MY PI20033067 A MYPI20033067 A MY PI20033067A MY PI20033067 A MYPI20033067 A MY PI20033067A MY 142579 A MY142579 A MY 142579A
Authority
MY
Malaysia
Prior art keywords
aerosol formulation
anticholinergic
inhalation
anticlinergics
propellant
Prior art date
Application number
MYPI20033067A
Inventor
Friedrich Dr Schmidt
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31979448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY142579(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10237232A external-priority patent/DE10237232A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY142579A publication Critical patent/MY142579A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE PRESENT INVENTION RELATES TO A PROPELLANT-FREE AQUEOUS AEROSOL FORMULATION FOR ANTICLINERGICS OF FORMULA 1 WHEREIN X-DENOTES AN ANION.
MYPI20033067A 2002-08-14 2003-08-12 Aerosol formulation for inhalation comprising an anticholinergic MY142579A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10237232A DE10237232A1 (en) 2002-08-14 2002-08-14 Aqueous solution for inhalation, useful for treating respiratory disease, contains anticholinergic tricyclo-oxa-aza-nonane derivative and requires no propellant
DE10240257 2002-08-31

Publications (1)

Publication Number Publication Date
MY142579A true MY142579A (en) 2010-12-15

Family

ID=31979448

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20033067A MY142579A (en) 2002-08-14 2003-08-12 Aerosol formulation for inhalation comprising an anticholinergic

Country Status (31)

Country Link
EP (2) EP1530464B1 (en)
JP (1) JP4602767B2 (en)
KR (1) KR101060972B1 (en)
CN (1) CN1674887A (en)
AT (1) ATE400265T1 (en)
AU (1) AU2003298473B9 (en)
BR (1) BR0313457A (en)
CA (1) CA2495275C (en)
CY (1) CY1108776T1 (en)
DE (1) DE50310117D1 (en)
DK (1) DK1530464T3 (en)
EA (1) EA009936B1 (en)
EC (1) ECSP055600A (en)
ES (1) ES2305479T3 (en)
HR (1) HRP20050132A2 (en)
IL (1) IL166814A (en)
MX (1) MXPA05001595A (en)
MY (1) MY142579A (en)
NO (1) NO20051287L (en)
NZ (1) NZ538743A (en)
PE (1) PE20040372A1 (en)
PL (1) PL375511A1 (en)
PT (1) PT1530464E (en)
RS (1) RS51396B (en)
SA (1) SA03240265B1 (en)
SI (1) SI1530464T1 (en)
TW (1) TWI317279B (en)
UA (1) UA81775C2 (en)
UY (1) UY27938A1 (en)
WO (1) WO2004022052A1 (en)
ZA (1) ZA200410325B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004038885A1 (en) * 2004-08-10 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005001297A1 (en) * 2005-01-12 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055960A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055963A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055958A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055957A1 (en) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
WO2010133294A2 (en) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and atomizer
EA026241B1 (en) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Nebulizer
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
PL2835146T3 (en) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizer
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
PT3099172T (en) 2014-01-31 2021-11-08 Agbiome Inc Modified biological control agents and their uses
US9877486B2 (en) 2014-01-31 2018-01-30 AgBiome, Inc. Methods of growing plants using modified biological control agents
HUE055604T2 (en) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Nebulizer
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
EA035261B1 (en) 2014-05-07 2020-05-21 Бёрингер Ингельхайм Интернациональ Гмбх Nebulizer and container

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19653969A1 (en) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg New aqueous pharmaceutical preparation for the production of propellant-free aerosols
JP5392880B2 (en) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ Stable pharmaceutical solution formulation for pressurized metered dose inhalers
DE10050994A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
DE10063957A1 (en) * 2000-12-20 2002-06-27 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics and dopamine agonists
DE10200943A1 (en) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Process for the preparation of scopine esters

Also Published As

Publication number Publication date
EP1908468A1 (en) 2008-04-09
CA2495275C (en) 2012-04-17
NZ538743A (en) 2006-05-26
SA03240265B1 (en) 2009-11-10
ATE400265T1 (en) 2008-07-15
ECSP055600A (en) 2005-04-18
EP1530464A1 (en) 2005-05-18
MXPA05001595A (en) 2005-04-25
AU2003298473A1 (en) 2004-03-29
CN1674887A (en) 2005-09-28
EA200500292A1 (en) 2005-10-27
RS20050074A (en) 2007-09-21
NO20051287D0 (en) 2005-03-11
CY1108776T1 (en) 2014-04-09
WO2004022052A1 (en) 2004-03-18
IL166814A (en) 2010-11-30
SI1530464T1 (en) 2008-12-31
KR20050049478A (en) 2005-05-25
TWI317279B (en) 2009-11-21
ZA200410325B (en) 2006-10-25
PL375511A1 (en) 2005-11-28
UY27938A1 (en) 2004-03-31
EA009936B1 (en) 2008-04-28
JP2006506345A (en) 2006-02-23
TW200406213A (en) 2004-05-01
AU2003298473B2 (en) 2009-04-23
DE50310117D1 (en) 2008-08-21
EP1530464B1 (en) 2008-07-09
CA2495275A1 (en) 2004-03-18
PE20040372A1 (en) 2004-08-03
HRP20050132A2 (en) 2006-05-31
NO20051287L (en) 2005-03-11
BR0313457A (en) 2005-06-21
KR101060972B1 (en) 2011-09-01
UA81775C2 (en) 2008-02-11
IL166814A0 (en) 2006-01-15
ES2305479T3 (en) 2008-11-01
RS51396B (en) 2011-02-28
AU2003298473B9 (en) 2011-06-09
JP4602767B2 (en) 2010-12-22
PT1530464E (en) 2008-08-28
DK1530464T3 (en) 2008-09-08

Similar Documents

Publication Publication Date Title
MY142579A (en) Aerosol formulation for inhalation comprising an anticholinergic
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
WO2002055496A8 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
MX2007005694A (en) Novel betulin derivatives, preparation thereof and use thereof.
PT1204643E (en) Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
BR0309117A (en) Inhalation kit comprising tiotropium inhalable powder
CA2510853A1 (en) Pyrrolopyrimidine derivatives
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
WO2003095455A3 (en) Substituted pyrazolopyrimidines
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
MXPA05006889A (en) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
UY27980A1 (en) INDOLES 2,7-REPLACED
WO2007060104A3 (en) Aerosol formulation for inhalation containing an anticholinergic agent
MXPA02011039A (en) Fungicidal combinations of active agents.
SE0102440D0 (en) New compound
DE60114640D1 (en) Antithrombosemittel
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
MXPA04005484A (en) Method for preparing echinocandin derivatives.
WO2001010860A3 (en) Quinazolinone and azaquinazolinone derivatives
NO20081587L (en) Aerosol formulation for inhalation